PCI Pharma Services Capacity Update October 2023: Small Molecule

In this October 2023 edition of the Outsourced Pharma Capacity Update, PCI's Jerome Detreille outlines how recent investments have greatly increased the available capacity for the manufacture and packaging of highly potent drug products, including solid oral and liquid dosage forms. These investments build on PCI's 35+ years of experience in the handling of potent drug products, and the decade of success of the UK site's original Contained Manufacturing Facility (CMF), which was launched in 2013.